Company profile
Citius Oncology company profile
Citius Oncology is a biopharmaceutical company that develops and commercializes oncology therapies. The company specializes in targeted therapies for cancer treatment, with a focus on immune-based approaches. The company recently gained FDA approval for LYMPHIR™, a therapy for relapsed or refractory cutaneous T-cell lymphoma.
Business identity
- Contact email
- [email protected]
- Phone number
- +1 908-967-6677
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2024-01-01, Year
Headquarters
- Headquarters
- Cranford, New Jersey, United States
- Postal code
- 07016
- Country code
- US
- Continent
- North America